Evolocumab reduces LDL-cholesterol levels in FH
- PMID: 32913308
- DOI: 10.1038/s41569-020-00448-6
Evolocumab reduces LDL-cholesterol levels in FH
Comment on
-
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.N Engl J Med. 2020 Oct 1;383(14):1317-1327. doi: 10.1056/NEJMoa2019910. Epub 2020 Aug 29. N Engl J Med. 2020. PMID: 32865373 Clinical Trial.
References
Original article
-
- Santos, R. D. et al. Evolocumab in pediatric heterozygous familial hypercholesterolemia. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2019910 (2020) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
